
Overview
I decided to go to medical school during the early part of college and then never really looked back. I enjoyed every discipline while I was in medical school and had a difficult time selecting a specialty, until I did a rotation in Hematology/Oncology. After observing the relationships that oncologists develop with patients and their families, I knew that medical oncology was the right place for me. Getting to know my patients and their families and helping them achieve their goals, despite a cancer diagnosis, has become extremely important to me. I also enjoy working as part of a multidisciplinary team to make sure that patients get the most comprehensive care possible. When I am not working, I enjoy spending time with family, reading, and running.
Dr. Uronis is rated as an Experienced provider by MediFind in the treatment of Metastatic Pleural Tumor. Her top areas of expertise are Gastroesophageal Junction Cancer, Colorectal Cancer, Pancreatic Cancer, Stomach Cancer, and Pancreaticoduodenectomy.
Her clinical research consists of co-authoring 63 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Uronis has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Duke Cancer Center
I am a part of the thoracic oncology program. I work with patients who have cancers of the lung, which includes non-small cell lung cancer, small cell lung cancer, and mesothelioma. My focus is on clinical care, clinical trials, and developing new therapies for these diseases. When I first meet with a patient, I want them to understand what their diagnosis is, because there are actually multiple diagnoses of lung cancer and each are treated differently. Then I discuss with a patient whether they are a candidate for therapies such as molecular therapy or immunotherapy, and make sure they have a clear understanding of the treatment plan. There are some very promising new therapies for these diseases and we are fortunate to have those available to patients here at Duke. That’s one of the unique things we offer as an academic medical center. Dr. Stinchcombe is rated as an Elite provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Duke Cancer Center
I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday. Dr. Melson is rated as an Elite provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Duke Cancer Center
Scott Antonia is an Oncologist in Durham, North Carolina. Dr. Antonia has been practicing medicine for over 36 years and is rated as an Elite provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Gastroesophageal Junction Cancer
- Distinguished
- Anal CancerDr. Uronis isDistinguished. Learn about Anal Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Uronis isDistinguished. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Colorectal CancerDr. Uronis isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Uronis isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Uronis isDistinguished. Learn about Familial Pancreatic Cancer.
- Lynch SyndromeDr. Uronis isDistinguished. Learn about Lynch Syndrome.
- Advanced
- Adult Soft Tissue SarcomaDr. Uronis isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Ampullary CancerDr. Uronis isAdvanced. Learn about Ampullary Cancer.
- Clear Cell SarcomaDr. Uronis isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Uronis isAdvanced. Learn about Familial Prostate Cancer.
- MesotheliomaDr. Uronis isAdvanced. Learn about Mesothelioma.
- PancreatoblastomaDr. Uronis isAdvanced. Learn about Pancreatoblastoma.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Uronis isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Appendix CancerDr. Uronis isExperienced. Learn about Appendix Cancer.
- EGFR Positive Lung CancerDr. Uronis isExperienced. Learn about EGFR Positive Lung Cancer.
- Esophageal CancerDr. Uronis isExperienced. Learn about Esophageal Cancer.
- Fibrolamellar CarcinomaDr. Uronis isExperienced. Learn about Fibrolamellar Carcinoma.
- Gallbladder AdenocarcinomaDr. Uronis isExperienced. Learn about Gallbladder Adenocarcinoma.


